iX Biopharma Ltd. | Balance Sheet
Fiscal year is July-June. All values SGD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
15,961.00
8,891.00
31,327.00
31,088.00
21,066.00
Total Accounts Receivable
1,184.70
1,738.00
4,884.00
2,973.00
2,033.00
Inventories
-
-
-
-
528.00
Other Current Assets
31.20
306.00
542.00
521.00
486.00
Total Current Assets
17,176.80
10,935.00
36,753.00
34,582.00
24,113.00
Net Property, Plant & Equipment
2,587.60
2,169.00
7,541.00
8,191.00
8,096.00
Intangible Assets
2,936.00
2,236.00
1,793.00
1,398.00
865.00
Other Assets
-
60.00
23.00
79.00
-
Total Assets
22,700.50
15,400.00
46,110.00
44,250.00
33,074.00
ST Debt & Current Portion LT Debt
90.00
84.00
207.00
271.00
285.00
Accounts Payable
394.00
607.00
1,156.00
877.00
6,776.00
Income Tax Payable
258.10
183.00
240.00
217.00
-
Other Current Liabilities
1,342.00
3,376.00
1,926.00
2,573.00
71.00
Total Current Liabilities
2,084.20
4,250.00
3,529.00
3,938.00
7,132.00
Long-Term Debt
243.70
397.00
4,045.00
4,480.00
4,254.00
Provision for Risks & Charges
13.30
14.00
30.00
65.00
61.00
Deferred Taxes
716.60
391.00
248.00
107.00
90.00
Other Liabilities
1,107.60
-
-
-
-
Total Liabilities
4,165.30
5,052.00
7,852.00
8,590.00
11,537.00
Common Equity (Total)
18,476.60
10,244.00
38,191.00
35,625.00
21,520.00
Total Shareholders' Equity
18,476.60
10,244.00
38,191.00
35,625.00
21,520.00
Total Equity
18,476.60
10,244.00
38,191.00
35,625.00
21,520.00
Liabilities & Shareholders' Equity
22,700.50
15,400.00
46,110.00
44,250.00
33,074.00
Non-Equity Reserves
58.70
104.00
67.00
35.00
17.00
About iX Biopharma
View Profile
